Insightsclaudio.dangelo@spexcapital.com2025-09-12T13:35:52+01:00

Insights

Insights

Log my Care – Our Journey to Success

claudio.dangelo@spexcapital.com2025-09-12T13:32:52+01:00March 29, 2022|Profile|

Mobihealth News: What’s next for digital health in 2022?

claudio.dangelo@spexcapital.com2025-09-12T13:32:54+01:00December 29, 2021|News|

Doctor vs Machine: The Future of Medical Diagnostics

claudio.dangelo@spexcapital.com2025-09-12T13:32:54+01:00October 21, 2021|Report|

Mobihealth News: Spex Capital & Medcity joint investment call

claudio.dangelo@spexcapital.com2025-09-12T13:32:54+01:00September 24, 2021|News|

Yahoo Finance: Spex Capital and MedCity joint investment call goes live to source and fund breakthrough health-tech ventures

claudio.dangelo@spexcapital.com2025-09-12T13:32:54+01:00September 15, 2021|News|

TechRound: Claudio D’Angelo, MD at Spex Capital: The Impact of COVID-19 on HealthTech And Strategic Guidance For Health Tech Start Ups

claudio.dangelo@spexcapital.com2025-09-12T13:32:54+01:00August 18, 2021|News|

Spex Capital and MedCity partner to drive investment in promising health tech ventures

claudio.dangelo@spexcapital.com2025-09-12T13:32:54+01:00August 5, 2021|News|

MEDCITY Q&A: Claudio D’Angelo – Spex Capital

claudio.dangelo@spexcapital.com2025-09-12T13:32:54+01:00July 29, 2021|Profile|

Laing Buisson News: Spex Capital joins forces with MedCity to fund early stage health tech

claudio.dangelo@spexcapital.com2025-09-12T13:32:54+01:00July 22, 2021|News|

CB Insights: State of healthcare report Q1 2021

claudio.dangelo@spexcapital.com2025-09-12T13:32:54+01:00June 15, 2021|Report|

A tough year for start-ups

claudio.dangelo@spexcapital.com2025-09-12T13:32:44+01:00January 10, 2023|News|

Life from Banking to VC, an insight by Veronika Kuchinskiy

claudio.dangelo@spexcapital.com2025-09-12T13:32:46+01:00November 29, 2022|Corporate|

Skin Analytics – Our Journey to Success

claudio.dangelo@spexcapital.com2025-09-12T13:32:47+01:00November 1, 2022|Profile|

Previous 123 Next